Aaron Solis

Aaron Solis has extensive work experience in the biotechnology and pharmaceutical industry. Aaron currently holds the position of Sr. Director, Business Development at Cellipont Bioservices since January 2023. Prior to that, they were the President of DLABS LLC from June 2021 onwards. Aaron also worked as the Director, Business Development at AGC Biologics from July 2021 to June 2022.

Before joining AGC Biologics, Aaron held various roles at Catalent Pharma Solutions, including Director, Business Development from September 2020 to June 2021 and Director, Cell Therapy Manufacturing from February 2020 to September 2020. Aaron also served as the Director of Manufacturing at MaSTherCell from September 2019 to February 2020.

Aaron's earlier experiences include working at Lonza, where they were a Proposal Manager from March 2019 to September 2019, a Sr. Manufacturing Project Specialist from August 2018 to March 2019, a Supervisor, Commercial Manufacturing from April 2017 to August 2018, and a Core Technician IV from August 2015 to April 2017. Aaron began their career as a Tissue Engineer at Baylor College of Medicine from September 2010 to August 2015 and as a Medical Technician II at MD Anderson Cancer Center from November 2009 to September 2010.

From 2004 to 2008, Aaron Solis attended Baylor University, where they pursued a Bachelor of Science (BS) degree in Chemistry.